Page 12 - John Eade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inside Hijaz College, Nuneaton's Islamic University When the founder died, it led to one of the biggest funerals in the history of Coventry The video will auto-play soon8Cancel Play now Never miss another Warwickshire story by signing up to our free email updatesInvalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You c...

Getty Images Industrial stocks are expected to receive a shot in the arm in 2021, say analysts who specialize in the sector. Industrials were hammered when the U.S. economy was idled by COVID-19 and the slew of shutdown orders that followed to help slow the spread of the coronavirus. Now, however, with vaccines on the way, analysts' outlook for an economic recovery in 2021 is much more optimistic. "Expect strong catch-up growth in 2021 and the following years," say Morningstar analysts Preston Caldwell and Karen Andersen. Just note that industrials stocks might not take off immediately in 202...

A quiet trend continues to emerge in stocks that isn't receiving enough attention, according to CNBC's Jim Cramer: a stock shortage at a time when the average American is saving more money and investing in risk-averse index funds. What He Said The economy continues to perform well for the... Read More...

Order Reprints Text size GE stock is in a bullish pattern of higher highs and higher lows, says Argus analyst John Eade. Sebastien Bozon/AFP via Getty Images General Electric stock is in a bullish pattern of higher highs and higher lows, says Argus Research analyst John Eade. Thursday, he raised his price target to $14 a share, matching the Street-high target price. Eade believes the turnaround under GE (ticker: GE) CEO Larry Culp is making progress, which is evident despite a brutal year plagued by Covid-19. “While the company’s Healthcare segment is expe...